HLA-C*05 antigen

Also Known As:

HLA Cw5; HLA-Cw5

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6
      - Histocompatibility Antigens Class I: 1944
        HLA-C Antigens: 714
        HLA-C*05 antigen: 6

Experts

1.	Alaez, Carmen: 1 article (12/2010)
2.	Dorak, M Tevfik: 1 article (12/2010)
3.	Flores, Hilario: 1 article (12/2010)
4.	Gorodezky, Clara: 1 article (12/2010)
5.	Morrison, Brittany A: 1 article (12/2010)
6.	Ucisik-Akkaya, Esma: 1 article (12/2010)
7.	Bilici, Mehmet: 1 article (04/2010)
8.	Cayır, Kerim: 1 article (04/2010)
9.	Gundogdu, Cemal: 1 article (04/2010)
10.	Okcu, Nihat: 1 article (04/2010)

Related Diseases

1.	Stomach Neoplasms (Stomach Cancer) 04/01/2010 - "It is probable that HLA-Cw5 is a risk factor for gastric cancer whereas HLA-DRB115 plays a protective role for this disease. " 04/01/2010 - "The study revealed that the HLA-Cw5 antigen is more prevalent in patients with gastric cancer (p=0.042) and that the HLA-DRB115 antigen is more prevelent in the control group (p=0.021). "
2.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/01/2010 - "We noted a female-specific risk association in childhood ALL (pooled odds ratio (OR) = 2.6, 95% confidence interval (CI) = 1.5-4.5, Mantel-Haenszel P = 0.0009) similar to the stronger association of DRB11501 in females with MS. Examination of an HLA-C 5' flanking region SNP rs9264942, known to correlate with HLA-C expression, showed a protective association in girls (OR = 0.4, 95% CI = 0.2-0.7, Mantel-Haenszel P = 0.0003) similar to the protective HLA-Cw05 association in MS. In a reference cell line panel, HLA-Cw5 homozygous samples (n = 8) were also homozygous for the minor allele of the SNP. "
3.	Hepatitis A (Hepatitis, Infectious) 05/01/2007 - "Atypical forms of the hepatitis A were often met in carriers of HLA-Cw5, 827-835, A3-814, A3-B21, A9-B21, whereas typical forms - in carriers of HLA-A10, Cw2, A10-A19, B8-813, 821-835. "
4.	Crohn Disease (Crohn's Disease) 01/01/1982 - "The frequency of HLA-Cw5 was slightly increased in Crohn's disease; however, the corrected p value was not significant. "
5.	Transitional Cell Carcinoma 04/15/1982 - "HLA-Cw5 was detected on 6/8 cultures of transitional cell carcinomas and this was confirmed by absorption analysis."

Related Drugs and Biologics

1.	Antigens
2.	HLA-DRB1*15 antigen
3.	HLA-DRB1 Chains (HLA DRB1)
4.	HLA-C Antigens (HLA-C)
5.	Peptides (Polypeptides)
6.	Amino Acids
7.	HLA-C*70 antigen
8.	HLA-A10 antigen